[tdc_zone][vc_row full_width=”stretch_row” el_class=”td-travel-header td-stretch-content” row_divider_top=”” content_align_vertical=”content-vert-top” tdc_css=”eyJhbGwiOnsiYmFja2dyb3VuZC1pbWFnZSI6InVybChcImh0dHBzOi8vd3d3LmRpd291LmNvbS93cC1jb250ZW50L3VwbG9hZHMvMjAxOS8wNS9hZHZhbmNlLWluLWJyZWFrdGhyb3VnaC1jYW5jZXItdHJlYXRtZW50LWVsaW1pbmF0ZXMtc2VyaW91cy1zaWRlLWVmZmVjdHMuanBnXCIpIiwiYmFja2dyb3VuZC1wb3NpdGlvbiI6ImNlbnRlciBjZW50ZXIiLCJkaXNwbGF5IjoiIn19″][vc_column][/vc_column][/vc_row][vc_row el_class=”td-Biotech-News”][vc_column]

[/vc_column][/vc_row][vc_row][vc_column]
- Advertisement -
[/vc_column][/vc_row][vc_row][vc_column]

5 myths about agricultural biotechnology – thatsfarming.com – Thats Farming

- Advertisement -Adrian Lomezzo dispels myths about agricultural biotechnology. There is no need for alternative agricultural practices It is important that scientists accept the political...

Impact of exosomal HIV-1 Tat expression on the human cellular proteome

The cover for issue 54 of Oncotarget features Figure 2, ‘Comparative proteomic profiling of the peptides/proteins identified from 293T, IL16lamp2b and mExo-Tat samples,’ by...

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore (NHCS) found that deactivating a specific protein - interleukin 11...
[vc_empty_space height=”2px”][/vc_column][/vc_row][vc_row][vc_column]

Disproportionate percentage of females with unexplained infertility have gene variants known...

AUGUSTA, Ga. (March 17, 2023) – About 17% of women with unexplained infertility also have gene variants known to cause disease, from common conditions...

Product development and drug delivery at Seda

insights from industryShanoo BudhdeoDirector of Pharmaceutical ScienceSeda Pharmaceutical Development Services In this interview, NewsMedical speaks with Shanoo about her career progression and role...

Final Human Brain Project Summit closes with a vision for the...

The ten-year European Flagship Human Brain Project (HBP) links brain research with computing and technology in a large-scale, interdisciplinary approach. During the HBP Summit,...
[/vc_column][/vc_row][vc_row][vc_column width=”2/3″]

AI model accelerates antibody production and clone selection

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With...

Groundbreaking trial aims for precise dietary data collection

Scientists are recruiting adults from across the UK to take part in a groundbreaking trial to accurately track what they eat and drink in...
[/vc_column][vc_column width=”1/3″]

AI model accelerates antibody production and clone selection

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With...

Groundbreaking trial aims for precise dietary data collection

Scientists are recruiting adults from across the UK to take part in a groundbreaking trial to accurately track what they eat and drink in...

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today...
[/vc_column][/vc_row][vc_row][vc_column]

more new items

AI model accelerates antibody production and clone selection

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With...

Groundbreaking trial aims for precise dietary data collection

Scientists are recruiting adults from across the UK to take part in a groundbreaking trial to accurately track what they eat and drink in...

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today...
[/vc_column][/vc_row][/tdc_zone]